Ad is loading...
TSHA
Price
$2.06
Change
-$0.21 (-9.25%)
Updated
Nov 15 closing price
129 days until earnings call
VCNX
Price
$3.16
Change
-$0.48 (-13.19%)
Updated
Nov 15 closing price
Ad is loading...

TSHA vs VCNX

Header iconTSHA vs VCNX Comparison
Open Charts TSHA vs VCNXBanner chart's image
Taysha Gene Therapies
Price$2.06
Change-$0.21 (-9.25%)
Volume$7.3M
CapitalizationN/A
Vaccinex
Price$3.16
Change-$0.48 (-13.19%)
Volume$49.04K
CapitalizationN/A
TSHA vs VCNX Comparison Chart
Loading...
TSHA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VCNX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
TSHA vs. VCNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TSHA is a StrongSell and VCNX is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (TSHA: $2.06 vs. VCNX: $3.16)
Brand notoriety: TSHA and VCNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TSHA: 207% vs. VCNX: 42%
Market capitalization -- TSHA: $422.18M vs. VCNX: $8.83M
TSHA [@Biotechnology] is valued at $422.18M. VCNX’s [@Biotechnology] market capitalization is $8.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TSHA’s FA Score shows that 0 FA rating(s) are green whileVCNX’s FA Score has 0 green FA rating(s).

  • TSHA’s FA Score: 0 green, 5 red.
  • VCNX’s FA Score: 0 green, 5 red.
According to our system of comparison, both TSHA and VCNX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TSHA’s TA Score shows that 4 TA indicator(s) are bullish while VCNX’s TA Score has 5 bullish TA indicator(s).

  • TSHA’s TA Score: 4 bullish, 5 bearish.
  • VCNX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, VCNX is a better buy in the short-term than TSHA.

Price Growth

TSHA (@Biotechnology) experienced а +37.33% price change this week, while VCNX (@Biotechnology) price change was +1.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

TSHA is expected to report earnings on Mar 26, 2025.

VCNX is expected to report earnings on Nov 13, 2023.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TSHA($422M) has a higher market cap than VCNX($8.83M). TSHA YTD gains are higher at: 16.384 vs. VCNX (-66.048). VCNX has higher annual earnings (EBITDA): -17.65M vs. TSHA (-110.75M). TSHA has more cash in the bank: 173M vs. VCNX (233K). VCNX has less debt than TSHA: VCNX (122K) vs TSHA (57.7M). TSHA has higher revenues than VCNX: TSHA (12.9M) vs VCNX (356K).
TSHAVCNXTSHA / VCNX
Capitalization422M8.83M4,778%
EBITDA-110.75M-17.65M628%
Gain YTD16.384-66.048-25%
P/E Ratio3.27N/A-
Revenue12.9M356K3,624%
Total Cash173M233K74,249%
Total Debt57.7M122K47,295%
FUNDAMENTALS RATINGS
VCNX: Fundamental Ratings
VCNX
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
TSHAVCNX
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
82%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
83%
View a ticker or compare two or three
Ad is loading...
TSHA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VCNX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OANLX81.51-0.60
-0.73%
Oakmark Select Institutional
NILIX13.51-0.17
-1.24%
Neuberger Berman International Sel I
MOJAX14.56-0.20
-1.36%
Donoghue Forlines Momentum A
JFCAX37.63-0.55
-1.44%
JHancock Fundamental All Cap Core A
SPFAX25.92-0.69
-2.59%
PGIM Jennison Focused Growth A

TSHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with LOGC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then LOGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
-9.25%
LOGC - TSHA
45%
Loosely correlated
+1.67%
ABOS - TSHA
40%
Loosely correlated
-8.05%
TERN - TSHA
39%
Loosely correlated
-5.80%
ORMP - TSHA
35%
Loosely correlated
-4.50%
PGEN - TSHA
34%
Loosely correlated
-7.11%
More

VCNX and

Correlation & Price change

A.I.dvisor tells us that VCNX and TSHA have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VCNX and TSHA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCNX
1D Price
Change %
VCNX100%
-13.31%
TSHA - VCNX
29%
Poorly correlated
-9.25%
SAGE - VCNX
29%
Poorly correlated
-5.03%
BRNS - VCNX
28%
Poorly correlated
-29.70%
ACET - VCNX
28%
Poorly correlated
-9.82%
DWTX - VCNX
28%
Poorly correlated
-7.19%
More